/PRNewswire/ Beta Bionics, Inc. The results of the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial (IO BPPT), which were presented in.
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found.
Nemours Children s Health, Jacksonville trial reveals that bionic pancreas improves type 1 diabetes management compared to standard miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.